Last reviewed · How we verify
Biafine cream
At a glance
| Generic name | Biafine cream |
|---|---|
| Sponsor | Radiation Therapy Oncology Group |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Study on the Prevention and Treatment of Radiation Vaginitis With Triethanolamine Cream (PHASE4)
- Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer . (NA)
- Skin Prick Test of KeraStat® Cream (NA)
- The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients (NA)
- Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer (PHASE3)
- Clinical Trial to Evaluate Biafine Cream Versus Standard Care in Subjects With Actinic Keratosis Post Cryotherapy (PHASE4)
- Comparison of Efficacy and Safety Between Medical Radiation Protectants (FORRAD®) and Trolamine (Biafine) for the Management of Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma Receiving IMRT (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Biafine cream CI brief — competitive landscape report
- Biafine cream updates RSS · CI watch RSS
- Radiation Therapy Oncology Group portfolio CI